Small-cap stocks are companies with market capitalizations of less than $2 billion. These stocks can be very volatile, and thus, could offer impressive returns in the short-term as well.
Additionally, what makes these stocks even more tempting is the Goldman Sachs data that small-cap stocks have outperformed the large-cap stocks over the past two decades, and the trend is expected to continue this year as well.
Let’s take a look at the five best and worst performing small-cap stocks in April 2022.
Five Best Performing Small-Cap Stocks In April 2022
We have used the April return data from finviz.com to come up with the five best and worst performing small-cap stocks in April 2022. Here they are in reverse order.
5. BlackBoxStocks (116%)
Founded in 2011 and headquartered in Dallas, this company makes available real-time proprietary analytics and news to stock and options traders. Blackboxstocks (NASDAQ:BLBX) shares are down over 51% YTD and over 10% in the last year.
Its shares are presently trading at over $1.80, while it has a 52-week range of $1.49 and $8.00. As of writing, BlackBoxStocks’ market cap was more than $22 million.
4. Redbox Entertainment (127%)
Redbox Entertainment (NASDAQ:RDBX), which was founded in 2002 and is headquartered in Oakbrook Terrace, Ill., produces, acquires and distributes movies through its Redbox Entertainment brand. Its shares are down almost 64% YTD and almost 73% in the last year, while presently they are being trading at over $2.40. RDBX has a 52-week range of $1.6101 and $27.22. As of writing, Redbox Entertainment’s market cap was more than $145 million.
3. Veru (136%)
This Miami, Fla. based company develops medicines for the management of prostate cancer and breast cancer. Shares of Veru (NASDAQ:VERU), which was founded i 1996, are up over 53% YTD and over 19% in the last year.
VERU is presently trading at over $9.60, while it has a 52-week range of $4.34 and $17.50. As of writing, Veru’s market cap was more than $650 million.
2. Checkmate Pharmaceuticals (222%)
Cambridge MA is where Checkmate Pharmaceuticals (NASDAQ:CMPI), founded in 2015, develops proprietary technology to use the immune system's power to combat cancer.
CMPI shares are up over 260% YTD and over 50% in the last year. Its shares are presently trading at over $10.40, while it has a 52-week range of $2.00 and $10.48. As of writing, Checkmate Pharmaceuticals’ market cap was more than $220 million.
1. Cyngn (275%)
Founded in 2013 and headquartered in Menlo Park, Calif., Cyngn (NASDAQ:CYN) is an autonomous vehicle technology company that focuses on finding industrial uses for autonomous vehicles.
CYN) shares are down over 15% YTD but are up over 140% in the last three months. Its shares are presently trading at over $3.60, while it has a 52-week range of $1.08 and $9.91. As of writing, Cyngn’s market cap was more than $90 million.
Five Worst Performing Small-Cap Stocks In April 2022
5. Agile Therapeutics (-76%)
Founded in 1997 and headquartered in Princeton, N.J., this healthcare company develops and commercializes transdermal patches. Agilent Technologies Inc (NYSE:NYSE:A) shares are down over 90% YTD and over 95% in the last year. Its shares are presently trading at over $1.60, while it has a 52-week range of $1.58 and $69.60. As of writing, Agile Therapeutics’ market cap was more than $6 million.
4. Iveda Solutions (-77%)
Iveda Solutions (OTC:IVDA) enables cloud video surveillance through its Sentir data and video management platform. Founded in 2003 and headquartered in Mesa, AZ, shares of IVDA are down over 90% YTD and over 80% in the last year.
The stock is presently trading at over $1.10, while it has a 52-week range of $0.9709 and $19.52. As of writing, Iveda Solutions’ market cap was more than $12 million.
3. Genocea Biosciences (-78%)
Headquartered in Cambridge, Mass., Genocea Biosciences' (NASDAQ:GNCA) shares are down over 85% YTD and over 90% in the last year. Its shares are presently trading at over $0.18, while it has a 52-week range of $0.1601 and $2.68. As of writing, Genocea Biosciences’ market cap was more than $9 million.
Founded in 2006, Genocea Biosciences develops and commercializes cancer vaccines.
2. Blue Water Vaccines (-93%)
Blue Water Vaccines, which was founded in 2018, is a biotechnology company focused on developing transformational vaccines to prevent infectious diseases worldwide. Shares of the Cincinnatti, OH headquartered company are up over 70% in the last five days. Its shares are presently trading over $6.50, while it has a 52-week range of $3.26 and $90.90. As of writing, Blue Water Vaccines’ market cap was more than $70 million.
1. Kaleido Biosciences (-97%)
Founded in 2015 and headquartered in Lexington, Mass., Kaleido Biosciences (NASDAQ:KLDO) is a clinical stage healthcare company that leverages the microbiome organ to treat disease and improve human health.
KLDO shares are down over 97% YTD and over 99% in the last one year. Its shares are presently trading over $0.04, while it has a 52-week range of $0.0411 and $9.470. As of writing, Kaleido Biosciences’ market cap was more than $2 million.